ClinicalTrials.Veeva

Menu

Comparison of Physical Function and Quality of Life in Insulin and Non-Insulin Users With Type 2 Diabetes

E

Eastern Mediterranean University

Status

Completed

Conditions

Type 2 Diabetes

Treatments

Other: NO INTERVENTION

Study type

Observational

Funder types

Other

Identifiers

NCT06935396
DAU-2025-T2D-INS01

Details and patient eligibility

About

This clinical trial aims to compare the muscle strength, functional exercise capacity, physical activity levels, and quality of life between insulin-using and non-insulin-using patients with Type 2 diabetes. The study will involve participants aged 40-70, diagnosed with Type 2 diabetes, and will assess their physical performance through a series of standardized tests. The primary objective is to determine if insulin use impacts the physical fitness and overall health of patients with Type 2 diabetes. Results from this study could lead to better management strategies for diabetic patients.

Full description

This study aims to analyzemuscle strength, functional exercise capacity, physical activity levels, and quality of life (QoL) among a control group, insulin-using, and non-insulin-using patients with Type 2 Diabetes Mellitus. A total of 67 individuals with a mean age of 54.68 ± 7.41 years were included in the study. Among these participants, 18 were insulin users (Group 1), 21 were non-insulin users (Group 2) with Type II Diabetes, and 28 were healthy individuals (Group 3). Demographic data of the participants were recorded. Grip strength was measured using a hand-grip dynamometer, and quadriceps strength was measured with a handheld dynamometer. Functional exercise capacity was evaluated using the 6-minute walk test (6 MWT), and physical activity levels were assessed using the International Physical Activity Questionnaire (IPAQ). The Short Form-12 questionnaire was used to assess QoL, the 30-second sit-to-stand test was used for lower extremity strength, and the Semmes-Weinstein Monofilament test was conducted to evaluate protective sensory loss.

Enrollment

67 patients

Sex

All

Ages

40 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Must have been diagnosed with Type 2 Diabetes Mellitus by a specialist doctor at least 5 years ago
  • Must be between 40-65 years of age
  • Must have signed the informed consent form
  • Must be literate

Exclusion criteria

  • Presence of active diabetic foot ulcer
  • History of acute trauma affecting the musculoskeletal system within the last month
  • Presence of musculoskeletal, orthopedic, neurological, or cardiopulmonary diseases
  • Participants who are unable to cooperate to the extent that they cannot understand the given instructions

Trial design

67 participants in 3 patient groups

Insulin-Using Type 2 Diabetes
Description:
Participants in this group are Type 2 Diabetes patients who are using insulin therapy. No specific drug dosage is administered as part of this study; the group is simply observed based on their existing insulin treatment regimen.
Non-Insulin-Using Type 2 Diabetes
Description:
This group consists of patients diagnosed with Type 2 Diabetes who are not using insulin. They may be managing their condition through oral medications or lifestyle changes, but no specific intervention is provided within the scope of this study.
Healthy Controls
Description:
This group consists of healthy individuals with no history of Type 2 Diabetes or any other chronic conditions. No medical intervention or treatment is administered, and they serve as a control group for comparison with the diabetic groups.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems